| Name | CB07-Exatecan |
|---|
| Description | CB07-Exatecan is an ADC drug-Linker conjugate that can be used for the synthesis of ADCs. ADC conjugated with CB07-Exatecan and trastuzumab inhibits the growth of HER2-positive cancer cells. CB07-Exatecan can be used in cancer research[1]. |
|---|---|
| Related Catalog | |
| References |
[1]. Weijia Tang, et al. Method for treating her2-positive solid tumor. Patent WO2023198079A1. |
| Molecular Formula | C71H94FN11O22 |
|---|---|
| Molecular Weight | 1472.56 |